Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
301087 Cofoe Medical Technology
- 39.39
- +1.27+3.33%
Market Closed Dec 12 15:00 CST
8.24BMarket Cap31.16P/E (TTM)
39.45High37.95Low27.33KlotVolume38.11Open38.12Pre Close106.74MTurnover3.02%Turnover Ratio32.39P/E (Static)209.09MShares46.9252wk High1.74P/B3.57BFloat Cap23.7552wk Low45.74Limit Up90.57MShs Float68.92Historical High30.50Limit Down3.94%Amplitude23.75Historical Low1.80Dividend TTM39.05Avg Price10.86KlotAsk4.57%Div YieldTTM100Lot Size15.44KlotBid
Cofoe Medical Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 5.87%2.25B | 2.60%1.56B | -5.64%807.15M | -4.14%2.85B | 13.11%2.12B | 17.23%1.52B | 42.38%855.37M | 30.82%2.98B | 10.60%1.88B | 17.84%1.3B |
| Operating revenue | 5.87%2.25B | 2.60%1.56B | -5.64%807.15M | -4.14%2.85B | 13.11%2.12B | 17.23%1.52B | 42.38%855.37M | 30.82%2.98B | 10.60%1.88B | 17.84%1.3B |
| Other operating revenue | ---- | 12.08%68.5M | ---- | 37.00%148.02M | ---- | 23.22%61.12M | ---- | -26.37%108.05M | ---- | -30.31%49.6M |
| Total operating cost | 5.68%1.97B | 3.76%1.34B | -0.02%676.81M | -1.96%2.59B | 7.31%1.87B | 10.27%1.29B | 26.29%676.95M | 44.43%2.65B | 29.08%1.74B | 37.18%1.17B |
| Operating cost | -5.79%1.09B | -6.19%768.79M | -3.05%404.95M | -10.11%1.62B | 0.03%1.16B | 2.93%819.48M | 13.29%417.71M | 40.87%1.8B | 22.77%1.16B | 31.18%796.12M |
| Operating tax surcharges | -12.00%19.24M | 21.31%13.21M | 11.88%6.9M | 46.46%28.83M | 104.84%21.87M | 55.68%10.89M | 101.57%6.17M | 3.83%19.69M | -26.99%10.67M | -21.95%6.99M |
| Operating expense | 35.49%711.66M | 31.99%466.69M | 11.55%218.53M | 19.62%740.7M | 20.98%525.23M | 25.31%353.59M | 57.12%195.9M | 49.49%619.19M | 43.19%434.16M | 48.84%282.17M |
| Administration expense | 4.17%95.7M | -1.62%61.17M | -8.71%29.52M | -8.78%110.92M | 6.84%91.87M | 11.79%62.18M | 14.64%32.34M | 113.85%121.6M | 139.41%85.99M | 147.18%55.62M |
| Financial expense | -37.71%-16.44M | -73.62%-12.91M | -16.89%-5.46M | 42.74%-19.06M | 45.06%-11.94M | 48.74%-7.43M | 52.03%-4.67M | -405.86%-33.29M | -873.38%-21.73M | -1,386.60%-14.5M |
| -Interest expense (Financial expense) | 90.62%13.12M | -1.53%8.51M | 3.10%2.72M | 24.45%13.5M | -13.28%6.88M | 30.99%8.64M | 19.08%2.64M | 59.38%10.85M | 94.31%7.94M | 158.19%6.59M |
| -Interest Income (Financial expense) | -35.89%-32.18M | -30.31%-22.07M | -6.35%-9.53M | 25.25%-34.31M | 33.72%-23.68M | 22.87%-16.94M | 37.77%-8.96M | -218.53%-45.89M | -1,495.33%-35.73M | -1,029.37%-21.96M |
| Research and development | -12.41%69.41M | -17.32%45.83M | -24.18%22.37M | -3.46%114.33M | 12.77%79.24M | 17.48%55.43M | 39.82%29.5M | 67.77%118.42M | 52.55%70.27M | 78.21%47.18M |
| Credit Impairment Loss | -179.07%-3.77M | -159.62%-2.69M | -145.78%-3.1M | 94.43%-821.15K | 222.24%4.77M | 155.53%4.51M | 78.01%-1.26M | -41.97%-14.75M | 58.64%-3.9M | -97.79%-8.12M |
| Asset Impairment Loss | 37.50%-31.68M | 34.01%-26.47M | 36.29%-21.44M | -12.69%-52.18M | -159.70%-50.68M | -141.72%-40.11M | -440.32%-33.66M | -159.53%-46.3M | -21.91%-19.52M | -51.95%-16.59M |
| Other net revenue | -20.19%18.96M | -112.42%-1.23M | 46.94%-11.06M | -6.15%35.42M | -56.54%23.75M | -68.47%9.91M | -304.19%-20.85M | -44.22%37.74M | 233.00%54.65M | 84.68%31.42M |
| Fair value change income | -92.54%2.49M | -111.62%-2.55M | -25.28%7.54M | -135.50%-1.56M | -2.33%33.36M | -17.46%21.98M | 749.05%10.09M | -30.47%4.4M | --34.16M | --26.63M |
| Invest income | 1,485.88%15.04M | 61,756.89%13.07M | -3,528.76%-431.7K | -15.92%47.72M | -45.93%948.55K | -102.28%-21.2K | -100.80%-11.9K | 18,624.16%56.75M | 995.00%1.75M | 216.50%929.92K |
| -Including: Investment income associates | 624.05%462.02K | -58.56%-101.77K | -3,528.76%-431.7K | -519.85%-130.24K | -212.02%-88.16K | -348.32%-64.19K | -165.20%-11.9K | 93.14%-21.01K | 85.58%-28.26K | 103.24%25.85K |
| Asset deal income | -101.10%-53.86K | -96.27%89.9K | -30.74%63.21K | -29.07%4.59M | 50.97%4.88M | 317.30%2.41M | 54.78%91.27K | 4,546.87%6.47M | 5,628.78%3.24M | 5,364.12%578.14K |
| Other revenue | 21.19%36.93M | -18.04%17.32M | 61.76%6.31M | 20.89%37.68M | -21.70%30.47M | -24.53%21.13M | -42.76%3.9M | -65.27%31.17M | -7.32%38.91M | -14.71%28M |
| Operating profit | 4.92%294.75M | -8.64%214.6M | -24.30%119.28M | -20.00%294.73M | 45.60%280.94M | 52.85%234.9M | 164.52%157.56M | -27.91%368.41M | -47.37%192.95M | -41.15%153.68M |
| Add:Non operating Income | 2,038.69%4.21M | 2,772.25%4.05M | 377.61%488.9K | -13.00%381.6K | -40.90%196.91K | -33.76%141.04K | -27.63%102.36K | 36.59%438.61K | -69.54%333.18K | 35.92%212.92K |
| Less:Non operating expense | -17.11%4.01M | -33.65%2.52M | -51.77%1.02M | -72.71%9.4M | 71.12%4.83M | 67.96%3.79M | 145.03%2.13M | 1,039.20%34.46M | 10.68%2.83M | 174.54%2.26M |
| Total profit | 6.75%294.96M | -6.54%216.14M | -23.66%118.74M | -14.56%285.71M | 45.07%276.3M | 52.51%231.25M | 164.34%155.54M | -34.22%334.39M | -47.84%190.46M | -41.78%151.63M |
| Less:Income tax cost | 26.81%43.02M | -0.27%31.43M | -20.14%17.7M | 1.45%32.84M | 58.63%33.92M | 60.89%31.52M | 257.08%22.17M | -58.89%32.37M | -64.61%21.39M | -55.82%19.59M |
| Net profit | 3.94%251.94M | -7.52%184.7M | -24.24%101.04M | -16.27%252.87M | 43.36%242.38M | 51.26%199.73M | 153.41%133.37M | -29.70%302.02M | -44.51%169.07M | -38.90%132.04M |
| Net profit from continuing operation | 3.94%251.94M | -7.52%184.7M | -24.24%101.04M | -16.27%252.87M | 43.36%242.38M | 51.26%199.73M | 153.41%133.37M | -29.70%302.02M | -44.51%169.07M | -38.90%132.04M |
| Less:Minority Profit | -94.94%21.3K | -133.26%-273.39K | 83.99%-182.55K | -519.18%-1.41M | -73.48%420.61K | -54.52%821.96K | -146.98%-1.14M | -53.90%336.18K | 450.16%1.59M | 261.18%1.81M |
| Net profit of parent company owners | 4.12%251.92M | -7.00%184.98M | -24.75%101.22M | -15.71%254.28M | 44.47%241.96M | 52.73%198.91M | 167.93%134.51M | -29.65%301.68M | -44.98%167.48M | -39.60%130.24M |
| Earning per share | ||||||||||
| Basic earning per share | 6.90%1.24 | -4.21%0.91 | -23.08%0.5 | -14.48%1.24 | 45.00%1.16 | 53.23%0.95 | 170.83%0.65 | -44.23%1.45 | -58.97%0.8 | -55.07%0.62 |
| Diluted earning per share | 6.03%1.23 | -5.26%0.9 | -24.62%0.49 | -14.48%1.24 | 45.00%1.16 | 50.79%0.95 | 170.83%0.65 | -44.23%1.45 | -58.97%0.8 | -54.35%0.63 |
| Other composite income | ||||||||||
| Total composite income | 3.94%251.94M | -7.52%184.7M | -24.24%101.04M | -16.27%252.87M | 43.36%242.38M | 51.26%199.73M | 153.41%133.37M | -29.70%302.02M | -44.51%169.07M | -38.90%132.04M |
| Total composite income of parent company owners | 4.12%251.92M | -7.00%184.98M | -24.75%101.22M | -15.71%254.28M | 44.47%241.96M | 52.73%198.91M | 167.93%134.51M | -29.65%301.68M | -44.98%167.48M | -39.60%130.24M |
| Total composite income of minority owners | -94.94%21.3K | -133.26%-273.39K | 83.99%-182.55K | -519.18%-1.41M | -73.48%420.61K | -54.52%821.96K | -146.98%-1.14M | -53.90%336.18K | 450.16%1.59M | 261.18%1.81M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
